Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -102,985 | -101,660 | -141,936 | -99,836 | -71,290 |
| Depreciation Amortization | 10,947 | 7,975 | 4,478 | 4,401 | 2,756 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -73 |
| Accounts receivable | -10,438 | -8,141 | 2,260 | -5,928 | -1,830 |
| Other Working Capital | -4,781 | -4,841 | 5,736 | -3,857 | 1,972 |
| Other Operating Activity | 23,575 | 11,706 | 30,614 | 23,915 | 22,653 |
| Operating Cash Flow | $-83,682 | $-94,961 | $-98,848 | $-81,305 | $-45,812 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 17,604 | 18,398 | -36,002 | N/A |
| PPE Investments | -5,964 | -6,995 | -8,156 | -4,013 | -10,155 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 4,626 |
| Purchase Sale Intangibles | -1,200 | -2,400 | -1,200 | N/A | -350 |
| Other Investing Activity | -1,200 | 9,488 | 8,582 | -209 | -531 |
| Investing Cash Flow | $-7,164 | $20,097 | $18,824 | $-40,224 | $-6,060 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 15,000 | N/A | N/A | N/A |
| Debt Issued | 60,000 | N/A | 21,707 | 30,855 | 7,920 |
| Debt Repayment | -78,223 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 46,479 | 106,983 | 23,390 | 95,335 | 39,851 |
| Common Stock Repurchased | -70 | 0 | N/A | N/A | N/A |
| Dividend Paid | -6,752 | -2,559 | -2,344 | -299 | N/A |
| Other Financing Activity | 150,976 | 27,290 | 7,895 | 24,490 | -4,866 |
| Financing Cash Flow | $172,410 | $146,714 | $50,648 | $150,381 | $42,905 |
| Beginning Cash Position | 153,432 | 81,582 | 110,958 | 82,106 | 113,121 |
| End Cash Position | 234,996 | 153,432 | 81,582 | 110,958 | 104,154 |
| Net Cash Flow | $81,564 | $71,850 | $-29,376 | $28,852 | $-8,967 |
| Free Cash Flow | |||||
| Operating Cash Flow | -83,682 | -94,961 | -98,848 | -81,305 | -45,812 |
| Capital Expenditure | -5,964 | -6,995 | -8,156 | -4,013 | -10,155 |
| Free Cash Flow | -89,646 | -101,956 | -107,004 | -85,318 | -55,967 |